Taysha Gene Therapies (TSHA) PT Raised to $8 at Canaccord Genuity
Tweet Send to a Friend
(Updated - November 15, 2024 7:07 AM EST)
Canaccord Genuity analyst Whitney IJem raised the price target on Taysha ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
Canaccord Genuity analyst Whitney IJem raised the price target on Taysha ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
